RecruitingNot ApplicableNCT07000708

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle


Sponsor

Charite University, Berlin, Germany

Enrollment

24 participants

Start Date

Sep 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to investigate the effects of a four-week time-restricted eating (TRE) intervention on autophagy, immune function, and vaccine response to a seasonal influenza and COVID-19 vaccines in older healthy subjects.


Eligibility

Min Age: 60 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called TRE: Time-restricted eating for people with immunosenescence, metabolism, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTRE: Time-restricted eating

The daily eating pattern is reduced to 8 h/day. The first meal will be before 10:00 AM.


Locations(1)

Clinical Research Unit, Experimental & Clinical Research Center, Campus Buch, Charité

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07000708


Related Trials